StockData
Calidi Biotherapeutics, Inc. logo

Calidi Biotherapeutics, Inc. (CLDI) stock

CLDINYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CLDWW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$0.48−0.03 (-5.45%)

Close on Nov 20, 2026Market cap $1.23MP/E –Yield –

Calidi Biotherapeutics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Calidi Biotherapeutics

Calidi Biotherapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Calidi Biotherapeutics figures

See a number that looks wrong?